Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-063957
Filing Date
2025-05-06
Accepted
2025-05-06 07:10:23
Documents
74
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q upb-20250331.htm   iXBRL 10-Q 2380195
2 EX-31.1 upb-ex31_1.htm EX-31.1 17796
3 EX-31.2 upb-ex31_2.htm EX-31.2 17606
4 EX-32.1 upb-ex32_1.htm EX-32.1 15919
  Complete submission text file 0000950170-25-063957.txt   8731296

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT upb-20250331.xsd EX-101.SCH 1080252
77 EXTRACTED XBRL INSTANCE DOCUMENT upb-20250331_htm.xml XML 1471963
Mailing Address 890 WINTER STREET, SUITE 200 WALTHAM MA 02451
Business Address 890 WINTER STREET, SUITE 200 WALTHAM MA 02451 781-208-2466
Upstream Bio, Inc. (Filer) CIK: 0002022626 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42366 | Film No.: 25915209
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)